Abstract
We conducted a community seroprevalence survey in Arizona, from September 12 to October 1, 2020, to determine the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We used the seroprevalence estimate to predict SARS-CoV-2 infections in the jurisdiction by applying the adjusted seroprevalence to the county’s population. The estimated community seroprevalence of SARS-CoV-2 infections was 4.3 times greater (95% confidence interval52.2, 7.5) than the number of reported cases. Field surveys with representative sampling provide data that may help fill in gaps in traditional public health reporting.
Original language | English (US) |
---|---|
Pages (from-to) | 38-42 |
Number of pages | 5 |
Journal | American journal of public health |
Volume | 112 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2022 |
ASJC Scopus subject areas
- Public Health, Environmental and Occupational Health